Labcorp EVP Bryan T. Vaughn Sells $108K in Common Stock Under Rule 10b5-1 Plan
LABCORP HOLDINGS INC.
Subscribe to track LH
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📊 Insider Transaction Report: Labcorp Holdings Inc. ($LH)
Insider: Bryan T. Vaughn (EVP and President, Diagnostics) Transaction: Disposed / Sale (Code S) Shares Transacted: 306 @ $353.70 (~$108,232.20) Ownership Remaining: 6,844.91 shares (Direct) Details: Executed under a pre-established Rule 10b5-1 trading plan. Significance: Low
Comprehensive Analysis
Insider Transaction Overview
On November 3, 2026, Bryan T. Vaughn, Executive Vice President and President of Diagnostics at Labcorp Holdings Inc. ($LH), executed an open-market sale of common stock.
- Security: Common Stock
- Shares Sold: 306
- Price per Share: $353.70
- Total Transaction Value: $108,232.20
- Post-Transaction Beneficial Ownership: 6,844.9105 shares (Direct)
Context & Trading Plan
According to the filing, the transaction was executed pursuant to a pre-arranged Rule 10b5-1 trading plan. Such plans allow corporate insiders to set predetermined schedules for trading to avoid potential conflicts or concerns regarding material non-public information (MNPI).
Significance Assessment
The transaction represents a relatively minor reduction (~4.3%) in Mr. Vaughn's overall direct holdings, with a modest transaction size of approximately $108K. Given the pre-planned nature under Rule 10b5-1 and the modest dollar value, this transaction carries Low market significance.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.